platinum tetrachloride has been researched along with sk&f 86002 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guinea Viniegra, J; Hernández Losa, J; Parada Cobo, C; Ramón y Cajal, S; Sánchez-Arevalo Lobo, VJ; Sánchez-Prieto, R | 1 |
1 other study(ies) available for platinum tetrachloride and sk&f 86002
| Article | Year |
|---|---|
Role of the p38 MAPK pathway in cisplatin-based therapy.
Topics: Animals; Antineoplastic Agents; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Cell Survival; Cisplatin; COS Cells; Cross-Linking Reagents; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Drug Resistance, Neoplasm; Enzyme Activation; Enzyme Inhibitors; HeLa Cells; Humans; Imidazoles; Kinetics; MAP Kinase Kinase 3; MAP Kinase Kinase 6; Mitogen-Activated Protein Kinase 12; Mitogen-Activated Protein Kinase 13; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phenotype; Phosphorylation; Plasmids; Platinum Compounds; Precipitin Tests; Protein Isoforms; Protein-Tyrosine Kinases; Pyridines; Signal Transduction; Thiazoles; Transfection; Tumor Cells, Cultured | 2003 |